相关实验视频

Updated: Jul 10, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

一个基于瘤微环境和结直肠癌免疫细胞的预后模型

Yufu Lin¹, Yabo Chen², Lu Gan³

¹Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.

Scandinavian journal of gastroenterology

|November 18, 2023

概括

这项研究开发了一种新的与免疫相关的结直肠癌 (CRC) 预后签名,使用三个基因:HAMP,ADAM8和CD1B. 这种特征有助于理解CRC的进展和潜在的免疫治疗点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

大肠直肠癌 (CRC) 是癌症死亡的主要原因.
免疫疗法为癌症提供了一种新的治疗途径.
开发与免疫相关的生物标志物对于CRC管理至关重要.

研究的目的:

为了识别与免疫相关的基因特征,用于结直肠癌的预后.
建立基于免疫细胞相互作用的CRC患者结果的预测模型.

主要方法:

使用了差异基因表达分析和权重基因同表达网络分析 (WGCNA).
考克斯回归分析被用来构建预后特征.
用实时聚合酶链反应验证基因表达.

主要成果:

确定了三个预后基因 (HAMP,ADAM8,CD1B) 的签名.
年龄,阶段和开发的风险评分是显著的独立预后因素.
这三种特征基因在CRC组织中表达的显著高于正常组织.

结论:

成功确定了CRC的免疫相关预后特征,包括HAMP,ADAM8和CD1B.
这个签名为CRC研究和生物标志物开发提供了有价值的参考.
这些发现支持免疫细胞相关基因在CRC预后中的作用.

关键词:

结肠直肠癌是一种癌症.这是一个TCGA数据库.免疫疗法免疫疗法预后签名预测签名风险子组的风险子组.

更多相关视频

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...